COMMUNIQUÉS West-GlobeNewswire
-
Zhen-Ao Group Showcases Core 5'-Nucleotide Breakthroughs in Cambridge, Illuminating a Chinese Path for Global Technology-Driven Anti-Aging
10/04/2026 -
Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders
10/04/2026 -
Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026
10/04/2026 -
Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026
10/04/2026 -
TRICARE Now Covers Online Therapy in New York — $0 Copay for Active-Duty Families Through MMHC
10/04/2026 -
Vita Smart Cup Massager Claims Evaluated: 2026 Report on Suction Therapy, Red Light Technology, and What Consumers Should Know Before Buying
10/04/2026 -
Best ACV Gummies Claims Evaluated: What Ingredient Labels Actually Disclose vs. What Marketing Pages Emphasize — 2026 Consumer Transparency Update
10/04/2026 -
FDA Accepts NDA for TLX101-Px (Pixclara®)
10/04/2026 -
Standard Dental Labs Inc. Files 2025 Annual Report and Audited Financial Statements 2025 Following Transformational Year and Recent Acquisition Positioning Company for Potential, Significant Revenue Growth
09/04/2026 -
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference
09/04/2026 -
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
09/04/2026 -
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting
09/04/2026 -
Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.
09/04/2026 -
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
09/04/2026 -
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
09/04/2026 -
Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Want
09/04/2026 -
ClinNEXUS to Participate as Featured Speaker in Suncoast Ventures Gateway Conference on Healthcare Innovation
09/04/2026 -
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
09/04/2026 -
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
09/04/2026
Pages